Evidence map›Paper›PMID 24318876›Full record

ArticleThe Journal of biological chemistry2014

Altered expression of small heterodimer partner governs cytochrome P450 (CYP) 2D6 induction during pregnancy in CYP2D6-humanized mice.

Kwi Hye Koh, Xian Pan, Hong-Wu Shen, Samuel L M Arnold, Ai-Ming Yu, Frank J Gonzalez, Nina Isoherranen, Hyunyoung Jeong

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 52 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. P450-Humanized and Human Liver Chimeric Mouse Models for Studying Xenobiotic Metabolism and Toxicity.Drug metabolism and disposition: the biological fate of chemicals · 2018
    Review
  14. Article
  15. Article
  16. Review
  17. Inhibition of theDrug metabolism and disposition: the biological fate of chemicals · 2017
    Article
  18. High-Fat Diet Feeding Alters Expression of Hepatic Drug-Metabolizing Enzymes in Mice.Drug metabolism and disposition: the biological fate of chemicals · 2017
    Article
  19. Cholic Acid Feeding Leads to Increased CYP2D6 Expression in CYP2D6-Humanized Mice.Drug metabolism and disposition: the biological fate of chemicals · 2017
    Article
  20. Transcriptional Regulation of CYP2D6 Expression.Drug metabolism and disposition: the biological fate of chemicals · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Kwi Hye KohFrom the Department of Pharmacy Practice and.
Xian Pan
Hong-Wu Shen
Samuel L M Arnold
Ai-Ming Yu
Frank J Gonzalez
Nina Isoherranen
Hyunyoung Jeong
University of California Davis Medical Center · USUniversity of Illinois Chicago · USUniversity of Washington · USNational Institutes of Health · USUniversity of Illinois Urbana-Champaign · US

Funding

UIC Program for Interdisciplinary Careers in Women's Health ResearchK12HD055892 · NICHD · UNIVERSITY OF ILLINOIS AT CHICAGO · PI GELLER, STACIE E. · 2007 to 2016
$4.9M
Altered drug metabolism in pregnancyR01HD065532 · NICHD · UNIVERSITY OF ILLINOIS AT CHICAGO · PI JEONG, HYUNYOUNG · 2011 to 2015
$1.7M
NICHD NIH HHS HD065532NICHD NIH HHS K12 HD055892NICHD NIH HHS R01 HD065532
6 · The paper itself

Abstract

Substrates of a major drug-metabolizing enzyme CYP2D6 display increased elimination during pregnancy, but the underlying mechanisms are unknown in part due to a lack of experimental models. Here, we introduce CYP2D6-humanized (Tg-CYP2D6) mice as an animal model where hepatic CYP2D6 expression is increased during pregnancy. In the mouse livers, expression of a known positive regulator of CYP2D6, hepatocyte nuclear factor 4α (HNF4α), did not change during pregnancy. However, HNF4α recruitment to CYP2D6 promoter increased at term pregnancy, accompanied by repressed expression of small heterodimer partner (SHP). In HepG2 cells, SHP repressed HNF4α transactivation of CYP2D6 promoter. In transgenic (Tg)-CYP2D6 mice, SHP knockdown led to a significant increase in CYP2D6 expression. Retinoic acid, an endogenous compound that induces SHP, exhibited decreased hepatic levels during pregnancy in Tg-CYP2D6 mice. Administration of all-trans-retinoic acid led to a significant decrease in the expression and activity of hepatic CYP2D6 in Tg-CYP2D6 mice. This study provides key insights into mechanisms underlying altered CYP2D6-mediated drug metabolism during pregnancy, laying a foundation for improved drug therapy in pregnant women.

Indexed as

AnimalsAntineoplastic AgentsCytochrome P-450 CYP2D6Enzyme InductionFemaleHepatocyte Nuclear Factor 4Hep G2 CellsHumansLiverMiceMice, TransgenicPregnancyPromoter Regions, GeneticReceptors, Cytoplasmic and NuclearTranscriptional ActivationTretinoinAntineoplastic AgentsCytochrome P-450 CYP2D6Hepatocyte Nuclear Factor 4HNF4A protein, humanHnf4a protein, mousenuclear receptor subfamily 0, group B, member 2Receptors, Cytoplasmic and NuclearTretinoinCytochrome P450Drug MetabolismHNF4αPregnancyRetinoidSHPTransgenic Mice

Identifiers

PMID24318876
PMCPMC3916516
OpenAlexW1967942094

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.